BHST (BHST) Earnings Call Analysis

14/25

Growth 3 Margin 3 Expansion 4 Platform 2 Financial 2

latest quarter score

Earnings Reports

14
BioHarvest Sciences (BHST) Q2 2026: $20M Fragrance Contract Accelerates CDMO Revenue Shift
August 11, 2026
17
BioHarvest Sciences (BHST) Q1 2026: CDMO Pipeline Adds 3–4 New Projects, Deepening Royalty and Margin Leverage
June 17, 2026
22
BioHarvest Sciences (BHST) Q4 2025: CDMO Revenue Doubles as Strategic Bet on Plant Cell Tech Accelerates
June 16, 2026
23
BioHarvest Sciences (BHST) Q3 2025: 39% Revenue Growth Accelerates Path to Adjusted EBITDA Break-Even
November 13, 2025
22
BioHarvest Sciences (BHST) Q2 2025: 41% Revenue Growth Accelerates Path to Adjusted EBITDA Break-Even
August 11, 2025
22
BioHarvest Sciences (BHST) Q1 2025: Revenue Soars 47% as Botanical Synthesis Scales with CDMO Milestones
May 15, 2025
23
BioHarvest Sciences (BHST) Q4 2024: 99% Revenue Surge Validates Botanical Synthesis Growth and CDMO Expansion
March 31, 2025

Browse all companies